Journey Medical Corp ( (DERM) ) just unveiled an announcement.
On April 1, 2025, Journey Medical Corporation appointed Ramsey Alloush as Chief Operating Officer while he continues as General Counsel. Alloush, who joined the company in 2020, has played a significant role in its growth and strategic initiatives, including leading the IPO in 2021. His appointment comes at a pivotal time as the company prepares to launch Emrosi™, a new dermatological treatment expected to drive the company’s growth and redefine market standards.
More about Journey Medical Corp
Journey Medical Corporation is a commercial-stage pharmaceutical company based in Scottsdale, Arizona, specializing in the selling and marketing of FDA-approved prescription pharmaceutical products for dermatological conditions. The company markets eight FDA-approved drugs and was founded by Fortress Biotech, Inc.
YTD Price Performance: 56.00%
Average Trading Volume: 58,639
Technical Sentiment Signal: Strong Sell
Current Market Cap: $137.9M
For an in-depth examination of DERM stock, go to TipRanks’ Stock Analysis page.